Drug Profile
Research programme: antibacterials - Entomed
Alternative Names: Antibacterials research programme - EntomedLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Entomed
- Class Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections; Nosocomial infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in France
- 16 Jul 2016 No recent reports of development identified for preclinical development in Nosocomial-infections in France
- 20 Sep 2001 Preclinical development for Bacterial infections in France (Unknown route)